New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
08:03 EDTSPNCSpectranetics price target raised to $30 from $24 at Stifel
Stifel increased its price target on Spectranetics after the company announced positive results from its EXCITE ISR clinical trial. The firm sees the results as a major milestone for Spectranetics and keeps a Buy rating on the shares.
News For SPNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
16:13 EDTSPNCSpectranetics raises FY14 revenue view to $202M-$203.5M, consensus $201.98M
Subscribe for More Information
16:11 EDTSPNCSpectranetics reports Q3 EPS (5c), consensus (8c)
Reports Q3 revenue $58.8M, consensus $57.28M.
15:30 EDTSPNCNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use